TEVA PHARMACEUTICAL INDUSTRIES LIMITED Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 30.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2026-06-30 was 30.70M shares, a 1.60% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2026-03-31 was 9.40M shares, a 61.32% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-09-30 was 27.60M shares, a 46.62% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2025-06-30 was 31.20M shares.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2025 was 27.20M shares, a 47.79% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2024 was 52.10M shares, a 10.02% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2023 was 57.90M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | 30.70M shares 10-Q · filed 2026-07-29 | 30.70M shares 10-Q · filed 2026-07-29 | ||
| 2026-03-31 | 9.40M shares 10-Q · filed 2026-04-29 | |||
| 2025-12-31 | 27.20M shares 10-K · filed 2026-02-03 | |||
| 2025-09-30 | 27.60M shares 10-Q · filed 2025-11-05 | 28.60M shares 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 31.20M shares 10-Q · filed 2026-07-29 | 28.80M shares 10-Q · filed 2026-07-29 | ||
| 2025-03-31 | 24.30M shares 10-Q · filed 2026-04-29 | |||
| 2024-12-31 | 52.10M shares 10-K · filed 2026-02-03 | |||
| 2024-09-30 | 51.70M shares 10-Q · filed 2025-11-05 | 51.70M shares 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | 57.90M shares 10-K · filed 2026-02-03 |